PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious diseases, Skåne University Hospital, Lund, Sweden. karin.holm@med.lu.se.\', \'Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Region Skåne, Sweden.\', \'Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.\', \'Department of Clinical Microbiology, University and Regional Laboratories, Region Skåne, Sweden.\', \'Department of Infectious diseases, Skåne University Hospital, Lund, Sweden.\', \'Department of Clinical Microbiology, Umeå University, Umeå, Sweden.\', \'Department of Endocrinology, Skåne University Hospital, Lund, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13104-021-05847-7
?:doi
?:hasPublicationType
?:journal
  • BMC research notes
is ?:pmid of
?:pmid
?:pmid
  • 34863304
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.691
?:rankingScore_hIndex
  • 52
?:title
  • Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all